These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38656811)

  • 1.
    Hofstaedter CE; O'Keefe IP; Met CM; Wu L; Vanderwoude J; Shin S; Diggle SP; Riquelme SA; Rasko DA; Doi Y; Harro JM; Kopp BT; Ernst RK
    Am J Respir Cell Mol Biol; 2024 Aug; 71(2):207-218. PubMed ID: 38656811
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.
    Cigana C; Curcurù L; Leone MR; Ieranò T; Lorè NI; Bianconi I; Silipo A; Cozzolino F; Lanzetta R; Molinaro A; Bernardini ML; Bragonzi A
    PLoS One; 2009 Dec; 4(12):e8439. PubMed ID: 20037649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment in inflammasome signaling by the chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients results in an increase in inflammatory response.
    Phuong MS; Hernandez RE; Wolter DJ; Hoffman LR; Sad S
    Cell Death Dis; 2021 Mar; 12(3):241. PubMed ID: 33664232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Pseudomonas aeruginosa hepta-acylated lipid A variant associated with cystic fibrosis selectively activates human neutrophils.
    SenGupta S; Hittle LE; Ernst RK; Uriarte SM; Mitchell TC
    J Leukoc Biol; 2016 Nov; 100(5):1047-1059. PubMed ID: 27538572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent
    Hofstaedter CE; Chandler CE; Met CM; Gillespie JJ; Harro JM; Goodlett DR; Rasko DA; Ernst RK
    mBio; 2024 Feb; 15(2):e0282323. PubMed ID: 38131669
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic fibrosis epithelial cells.
    Parker D; Cohen TS; Alhede M; Harfenist BS; Martin FJ; Prince A
    Am J Respir Cell Mol Biol; 2012 Jan; 46(1):6-13. PubMed ID: 21778412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells.
    John G; Yildirim AO; Rubin BK; Gruenert DC; Henke MO
    Am J Respir Cell Mol Biol; 2010 Apr; 42(4):424-31. PubMed ID: 19502387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung.
    Malhotra S; Hayes D; Wozniak DJ
    J Cyst Fibros; 2019 Nov; 18(6):796-803. PubMed ID: 31036488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for cystic fibrosis transmembrane conductance regulator protein in a glutathione response to bronchopulmonary pseudomonas infection.
    Day BJ; van Heeckeren AM; Min E; Velsor LW
    Infect Immun; 2004 Apr; 72(4):2045-51. PubMed ID: 15039325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells.
    Greene CM; Carroll TP; Smith SG; Taggart CC; Devaney J; Griffin S; O'neill SJ; McElvaney NG
    J Immunol; 2005 Feb; 174(3):1638-46. PubMed ID: 15661927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor.
    Reiniger N; Lee MM; Coleman FT; Ray C; Golan DE; Pier GB
    Infect Immun; 2007 Apr; 75(4):1598-608. PubMed ID: 17283089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bacterial stimulation assay for bronchoalveolar lavage immune cells from young children with cystic fibrosis.
    Liu H; Sarkar S; Azzopardi K; Day S; Yeow S; Ranganathan S; Sutton P;
    Scand J Immunol; 2021 Jul; 94(1):e13040. PubMed ID: 33759233
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Li Z; Barnaby R; Nymon A; Roche C; Koeppen K; Ashare A; Hogan DA; Gerber SA; Taatjes DJ; Hampton TH; Stanton BA
    Am J Physiol Lung Cell Mol Physiol; 2024 May; 326(5):L574-L588. PubMed ID: 38440830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.
    Entezari M; Weiss DJ; Sitapara R; Whittaker L; Wargo MJ; Li J; Wang H; Yang H; Sharma L; Phan BD; Javdan M; Chavan SS; Miller EJ; Tracey KJ; Mantell LL
    Mol Med; 2012 May; 18(1):477-85. PubMed ID: 22314397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 4 is not targeted to the lysosome in cystic fibrosis airway epithelial cells.
    Kelly C; Canning P; Buchanan PJ; Williams MT; Brown V; Gruenert DC; Elborn JS; Ennis M; Schock BC
    Am J Physiol Lung Cell Mol Physiol; 2013 Mar; 304(5):L371-82. PubMed ID: 23316065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Septin-dependent defense mechanisms against Pseudomonas aeruginosa are stalled in cystic fibrosis bronchial epithelial cells.
    Brax S; Gaudin C; Calmel C; Boëlle PY; Corvol H; Ruffin M; Guillot L
    Eur J Cell Biol; 2024 Jun; 103(2):151416. PubMed ID: 38636185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic and Functional Characterization of Longitudinal Pseudomonas aeruginosa Isolates from Young Patients with Cystic Fibrosis.
    Chandler CE; Hofstaedter CE; Hazen TH; Rasko DA; Ernst RK
    Microbiol Spectr; 2023 Aug; 11(4):e0155623. PubMed ID: 37358436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
    Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
    Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss within the cystic fibrosis airway.
    Ernst RK; Adams KN; Moskowitz SM; Kraig GM; Kawasaki K; Stead CM; Trent MS; Miller SI
    J Bacteriol; 2006 Jan; 188(1):191-201. PubMed ID: 16352835
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Brao KJ; Wille BP; Lieberman J; Ernst RK; Shirtliff ME; Harro JM
    Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32631918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.